Meeting
2019 Genitourinary Cancers Symposium
MRI-TRUS fusion-guided biopsy in obese patients: Does it reduce risk of prostate cancer upgrade on final pathology compared to systematic 12-core biopsy?
Authors
Samuel A Gold
National Cancer Institute, Bethesda, MD
Samuel A Gold , Jonathan Bloom , Amir H Lebastchi , Graham Hale , Sherif Mehralivand , Thomas Sanford , Peter L. Choyke , Baris Turkbey , Peter A. Pinto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 110)
DOI
10.1200/JCO.2019.37.7_suppl.110
Abstract #
110
Poster Bd #
F12
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Is BMI a risk factor for active surveillance progression in patients with prostate cancer diagnosed by MRI-Trus fusion biopsy?
First Author: Kareem Rayn
Poster
2016 Gastrointestinal Cancers Symposium
Outcomes and toxicity in patients treated with bimodality or trimodality therapy for esophageal carcinoma with intensity modulated radiation therapy (IMRT).
First Author: Ajay Patel
Poster
2016 Genitourinary Cancers Symposium
MRI-US fusion targeted biopsy results in patients without history of prostate biopsy.
First Author: Cayce Nawaf
Poster
2016 Genitourinary Cancers Symposium
MRI-US fusion targeted biopsy results in men with a history of prior cancer.
First Author: Cayce Nawaf